Uncategorized

New Eli Lilly Drug Retatrutide Brought Major Weight Loss in Trial (Soban News)

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.​The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug. ​NYT > Business [ SOBAN NEWS: International and National ]

Related posts

How New Age IPOs Differ from Traditional Firms (Soban News)

News-Soban-Admin

If you want to hang us, we are ready: Cong’s Venugopal on Rahul LS notice (Soban News)

News-Soban-Admin

ED attaches ₹1,885 cr assets in alleged Reliance group bank fraud cases (Soban News)

News-Soban-Admin

Leave a Comment